{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T23:17:14Z","timestamp":1756682234290,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Timely monitoring of SARS-CoV-2 variants is crucial to effectively managing both prevention and treatment efforts. In this paper, we aim to describe demographic and clinical patterns of individuals with COVID-19-like symptoms during the first three epidemic waves in Mexico to identify changes in those patterns that may reflect differences determined by virus variants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a descriptive analysis of a large database containing records for all individuals who sought care at the Mexican Social Security Institute (IMSS) due to COVID-19-like symptoms from March 2020 to October 2021 (4.48 million records). We described the clinical and demographic profile of individuals tested (3.38 million, 32% with PCR and 68% with rapid test) by test result (positives and negatives) and untested, and among those tested, and the changes in those profiles across the first three epidemic waves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Individuals with COVID-19-like symptoms were older in the first wave and younger in the third one (the mean age for those positive was 46.6 in the first wave and 36.1 in the third wave; for negatives and not-tested, the mean age was 41 and 38.5 in the first wave and 34.3 and 33.5 in the third wave). As the pandemic progressed, an increasing number of individuals sought care for suspected COVID-19. The positivity rate decreased over time but remained well over the recommended 5%. The pattern of presenting symptoms changed over time, with some of those symptoms decreasing over time (dyspnea 40.6 to 14.0%, cough 80.4 to 76.2%, fever 77.5 to 65.2%, headache 80.3 to 78.5%), and some increasing (odynophagia 48.7 to 58.5%, rhinorrhea 28.6 to 47.5%, anosmia 11.8 to 23.2%, dysgeusia 11.2 to 23.2%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>During epidemic surges, the general consensus was that any individual presenting with respiratory symptoms was a suspected COVID-19 case. However, symptoms and signs are dynamic, with clinical patterns changing not only with the evolution of the virus but also with demographic changes in the affected population. A better understanding of these changing patterns is needed to improve preparedness for future surges and pandemics.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1102498","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:58:31Z","timestamp":1677481111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolution of differences in clinical presentation across epidemic waves among patients with COVID-like-symptoms who received care at the Mexican Social Security Institute"],"prefix":"10.3389","volume":"11","author":[{"given":"Gustavo","family":"Olaiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano M.","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Ju\u00e1rez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor H.","family":"Borja-Aburto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Vicu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n J.","family":"Ascencio-Montiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1126\/science.abp8715","article-title":"The huanan seafood wholesale market in wuhan was the early epicenter of the COVID-19 pandemic","volume":"377","author":"Worobey","year":"2022","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.14.22268821","article-title":"The risk of SARS-CoV-2 omicron variant emergence in low and middle-income countries (LMICs)","author":"Bi","year":"","journal-title":"medRxiv. [Preprint]."},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2021.01.044","article-title":"Public health actions to control new SARS-CoV-2 variants","volume":"184","author":"Grubaugh","year":"2021","journal-title":"Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.18502\/ijaai.v19i5.4461","article-title":"Variable clinical manifestations of COVID-19: viral and human genomes talk","volume":"19","author":"Imani-Saber","year":"2020","journal-title":"Iran J Allergy Asthma Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic variants of SARS-CoV-2-what do they mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e61312","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife."},{"volume-title":"Features, Evaluation, and Treatment of Coronavirus (COVID-19).","year":"2022","author":"Cascella","key":"B8"},{"key":"B9","doi-asserted-by":"publisher","first-page":"690621","DOI":"10.3389\/fcimb.2021.690621","article-title":"COVID-19 pandemic and vaccines update on challenges and resolutions","volume":"11","author":"Khan","year":"2021","journal-title":"Front Cell Infect Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e01056","DOI":"10.1128\/JVI.01056-20","article-title":"Genomic analysis of early SARS-CoV-2 variants introduced in Mexico","volume":"94","author":"Taboada","year":"2020","journal-title":"J Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3390\/v13112161","article-title":"Genetic analysis of SARS-CoV-2 variants in mexico during the first year of the COVID-19 pandemic","volume":"13","author":"Taboada","year":"2021","journal-title":"Viruses."},{"key":"B12","unstructured":"2021"},{"key":"B13","unstructured":"Coronavirus Pandemic (COVID-19)2020"},{"volume-title":"Encuesta Nacional de Salud y Nutrici\u00f3n 2021 sobre Covid-19.","year":"2022","author":"Shamah-Levy","key":"B14"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.12.22273734","article-title":"COVID-19 in the Mexican Social Security Institute (IMSS) population. prevalent symptoms","author":"Ju\u00e1rez-Flores","year":"","journal-title":"medRxiv. [Preprint]."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3064","article-title":"Age-varying susceptibility to the delta variant (B.1.617.2) of SARS-CoV-2","author":"Chun","year":"2022","journal-title":"JAMA Network Open"},{"journal-title":"Lineamiento estandarizado para la vigilancia epidemiol\u00f3gica y por laboratorio de la enfermedad respiratoria viral Ciudad de M\u00e9xico: Secretar\u00eda de Salud","year":"2021","key":"B17"},{"key":"B18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12875-022-01756-1","article-title":"Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice\u2013a prospective multicenter validation and implementation study","volume":"23","author":"Rohde","year":"2022","journal-title":"BMC Primary Care."},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD013705","DOI":"10.1002\/14651858.CD013705.pub3","article-title":"Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection","volume":"7","author":"Dinnes","year":"2022","journal-title":"Cochrane Database of Syst Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1009629","DOI":"10.1371\/journal.pcbi.1009629","article-title":"Modeling the onset of symptoms of COVID-19: effects of SARS-CoV-2 variant","volume":"17","author":"Larsen","year":"2021","journal-title":"PLoS Comput Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"957265","DOI":"10.3389\/fpubh.2022.957265","article-title":"Evolving trend change during the COVID-19 pandemic","volume":"10","author":"Gao","year":"2022","journal-title":"Front Public Health."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/S0140-6736(21)02867-1","article-title":"Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"837970","DOI":"10.3389\/fpubh.2022.837970","article-title":"Age-dependent risks of COVID-19 putatively caused by variant alpha in Japan","volume":"10","author":"Kayano","year":"2022","journal-title":"Front Public Health."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0245586","DOI":"10.1371\/journal.pone.0245586","article-title":"COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders","volume":"16","author":"Morlock","year":"2021","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1102498\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:58:35Z","timestamp":1677481115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1102498\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":24,"alternative-id":["10.3389\/fpubh.2023.1102498"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1102498","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"article-number":"1102498"}}